Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 797-804

  Ray, Anasuya ^a   Meng, Erhong ^a   Reed, Eddie ^a   Shevde, Lalita A ^a   Rocconi, Rodney P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Hedgehog; Ovarian cancer; Spheroid forming cells

Indexed keywords

CYCLOPAMINE; SONIC HEDGEHOG PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHEROID CELL; WESTERN BLOTTING;

CELL LINE; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; HEDGEHOG PROTEINS; HUMANS; OVARIAN NEOPLASMS; OVARY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; VERATRUM ALKALOIDS;

EID: 79960849567     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1093     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
2. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, De Geest K, Hartenbach EM and Baergen R: Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21: 3194-3200, 2003. (Pubitemid 46606249)
3. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006. (Pubitemid 44427449)
4. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I and Mor G: Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8: 158-166, 2009.
5. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
7. Azoulay S, Terry S, Chimingqi M, Sirab N, Faucon H, Gil Diez de Medina S, Moutereau S, Maille P, Soyeux P, Abbou C, Salomon L, Vacherot F, De la Taille A, Loric S and Allory Y: Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. J Pathol 216: 460-470, 2008.
8. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 64: 6071-6074, 2004. (Pubitemid 39129406)
9. Liao X, Siu MK, Au CW, Chan QK, Chan HY, Wong ES, Ip PP, Ngan HY and Cheung AN: Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin. Mod Pathol 22: 839-847, 2009.
10. Das S, Harris LG, Metge BJ, Liu S, Riker AI, Samant RS and Shevde LA: The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 284: 22888-22897, 2009.
11. Chen JK, Taipale J, Cooper MK and Beachy PA: Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16: 2743-2748, 2002. (Pubitemid 35253140)
12. Berman DM, Karhadkar SS, Maitra A, Montes de Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN and Beachy PA: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851, 2003. (Pubitemid 37351469)
13. Thayer SP, Di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL and Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856, 2003. (Pubitemid 37355945)
14. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB and Roth JA: A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 53: 4129-4133, 1993. (Pubitemid 24146752)
15. Rich JN: Cancer stem cells in radiation resistance. Cancer Res 67: 8980-8984, 2007.
16. Mimeault M, Hauke R, Mehta PP and Batra SK: Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11: 981-1011, 2007. (Pubitemid 350037046)
17. Seaberg RM and van der Kooy D: Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26: 125-131, 2003. (Pubitemid 36183673)
18. Wani AA, Sharma N, Shouche YS and Bapat SA: Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 25: 6336-6344, 2006. (Pubitemid 44564749)
19. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071, 2006.
20. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005. (Pubitemid 40488633)
21. Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M, Sayegh MH, Sadee W and Frank MH: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333, 2005. (Pubitemid 40775671)
22. Sadowski HB, Shuai K, Darnell JE Jr and Gilman MZ: A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261: 1739-1744, 1993. (Pubitemid 23332924)